Augmentation of streptozotocin-induced hyperglycemia in mice by prior treatment with complete freund’s adjuvant
Tóm tắt
The effect of complete Freund’s adjuvant (CFA), in combination with streptozotocin (STZ), on pancreatic insulin content, plasma glucose, and pancreatic histopathology were studied in male Balb/c mice. One injection of CFA, followed 24 h later by a single dose of 100 mg/kg of STZ (group I), produced a 92% (p<0.01) reduction in pancreatic insulin, a 54% (p<0.01) increase in glucagon content, and severe hyperglycemia. The depletion of pancreatic insulin was associated with degranulation, necrosis of beta cells, and reduction of the apparent islet size. Focal pancreatitis, without apparent islet inflammation, occurred in all animals in this group. After treatment with STZ alone (group II), pancreatic insulin content decreased 73% (p<0.01), whereas plasma glucose levels, even though being in the hyperglycemic range, were significantly lower (p<0.02) than the mice in group I. Although pyknotic and hypertrophic cell nuclei could be observed in several islets of mice from group II, major histopathological changes, such as pancreatitis and extensive beta cell necrosis seen in group I, were absent. The results show that in the Balb/c mouse strain, a nonspecific insult by CFA prior to a cell-specific cytotoxic insult markedly enhanced destruction of beta cells and the development of hyperglycemia.
Tài liệu tham khảo
Wellhausen S, Busby BT, and Rodman HM. Streptozotocin diabetes: an inadequate model for studies of immunity and infection. Diabetes 1984; 33: (1) 51 (abstract).
Rossini AA, Appel MC, Williams RM, and Like AA. Genetic influence of the streptozo-tocin-induced insulitis and hyperglycemia. Diabetes 1977; 26: 916–921.
Rossini AA, Like AA, Chick WL, Appel MC, and Cahill GF Jr. Studies of streptozoto-cin-induced insulitis and diabetes. Proc Natl Acad Sci USA. 1977; 74: 2485–2489.
Wilson GL, Patton NJ, McCord JM, Mullins DW, and Mossman BT. Mechanisms of streptozotocin- and alloxan-induced damage in rat B cells. Diabetologia 1984; 27: 587–591.
Like AA and Rossini AA. Streptozotocin-induced pancreatic insulitis: a new model of diabetes mellitus. Science 1976; 193: 415–417.
Ziegler M, Ziegler B, and Hehmke B. Severe hyperglycemia caused by autoimmunization to B-cells in rats. Diabetologia. 1984; 27: 163–165.
Kohnert KD, Odselius R, Fait K, Ziegler B, Ziegler M, and Falkmer S. Destruction of pancreatic beta cells in rats by complete Freund’s adjuvant combined with non-diabeto-genic doses of streptozotocin. Diabetes Research 1987; 5: 1–11.
Ziegler B, Tietz S, Kohnert KD, Koehler E, Knospe S, Kloeting I, and Ziegler M. Genetic control of diabetes induction by complete Freund’s adjuvant combined with subdiabeto-genic doses of streptozotocin in Lewis rats. Evidence for transient cytotoxicity against beta cells. Exp Clin Endocrinol 1987; 89: 269–275.
Richens ER, Tungekar MF, and Behbehani K. Complete Freund’s adjuvant has a differential amplification action on the induction of diabetes by streptozotocin in various murine strains: CFA amplifies STZ in murine diabetes. Pathology 1987; 19: 351–357.
Kiesel U, Kolb H, and Freytag G. Strain dependency of the transfer of experimental immune insulitis in mice. Clin Exp Immunol 1981; 43: 430–433.
Ziegler B, Hahn H-J, and Zielger M. Insulin recovery in pancreas and host organs of islet grafts. Exp Clin Endocrinol 1985; 85: 53–60.
Ziegler M, Keilacker H, Woltanski KP, Besch W, and Schubert J. Radioligandassays: Methodik und Anwendung. II. Einfluss der Glukagon-kupplung bei der Erzeusung von Antiglukagonseren mit geeigneten Bindungsparametern für den Radioimmunoassay. Acta Biol Med Ger 1980; 39: 305–314.
Hsu SM, Raine I, and Fanger H. A comparative study of the peroxidase method and an avidin-biotin complex method for studying poly-peptide hormone with radioimmunoassay antibodies. Am J Clin Pathol 1980; 75: 734–738.
Sternberger LR. Immunocytochemistry, 2nd ed., Wiley and Sons, New York, 1979; 104–169.
Diani AR, Sawada GA Hannah BA, Jodelis KS, Connell MA, Connell CL, Vidmar TJ, and Wyse BM. Analysis of pancreatic islet cell hormone content in the spontaneously diabetic KKAy mouse by morphometry, immunocytochemistry and radioimmunoassay. Virchows Arch A, 1987; 412: 53–61.
Toniolo A, Onodera T, Yoon JW, and Notkins AL. Induction of diabetes by cummulative environmental insults from viruses and chemicals. Nature 1980; 288: 383–385.
Blay RA, Bigley NJ, and Giron DJ. A murine model of insulin-dependent diabetes mellitus resulting from the cumulative effects of the nondiabetogenic strain of encephalomyo-carditis virus and a single low dose of streptozotocin. Diabetes 1985; 34: 1288–1292.
Dunbar JC and Brown A. Glucagon secretion by dispersed alpha cell enriched islets from streptozotocin treated hamsters in perifusion. Horm Metabol Res 1984; 16: 221–225.
Tomita T, Doull V, Kimmel JR, and Pollock HG. Comparison of PP, glucagon and insulin content in ob/ob and lean mice. Diabetologia 1984; 27: 454–459.
Hayashi H, Yoshinaga M, Koono M, Miyoshi M, and Matsunuma M. Endogenous permeability factors and their inhibitors affecting vascular permeability in cutaneous arthus reactions and thermal injury. Br J. Exp Pathol 1964; 45: 419–435.
Beppu H, Maruta K, Kuerner T, and Kolb H. Diabetogenic action of streptozotocin: essential role of membrane permeability. Acta Endocrinol (Kbh.) 1987; 114: 90–95.
Kloeppel G. “Insulin” induced insulitis. Acta Endocrinol (Kbh.) 1976; 205: 107–121.
Egeberg J, Junker K, Kromann H, and Nerup J. Autoimmune insulitis, pathological findings in experimental animal models and juvenile diabetes mellitus. Acta Endocrinol (Kbh.) 1976; 205: 129–137.
Huber SA, Babu PG, and Craighead JE. Genetic influences on the immunologie pathogenesis of encephalomyocarditis (EMC) virus-induced diabetes mellitus. Diabetes 1985; 34: 1186–1190.
Gould CL, McMannama KG, Bigley NJ, and Giron DJ. Virus-induced murine diabetes, enhancement by immunosuppression, Diabetes. 1985; 34: 1217–1221.
Kloeppel G. Islet histopathology in diabetes mellitus. Kloeppel G and Heitz PU, Eds., Pancreatic Pathology, Churchill Livingstone, London, 1984; 154–192.
Kothare SN. Pathological lesions in diabetes mellitus-their changing concepts. Indian J Med Sci 1974; 28: 103–107.
Warren S, LeCompte PM, and Legg MA. The Pathology of diabetes mellitus, 4th ed., Lea and Febiger, Philadelphia, 1966; 90–115.